FirstIgnite is supporting the commercialization of Florida International University’s novel tools for DNA topology and topoisomerases research technology. This innovative technology comprises fluorescently labeled circular DNA molecules, offering a rapid and cost-effective approach to study DNA topology and topoisomerases using fluorescence resonance energy transfer (FRET).
The immediate and future applications of this technology are to provide a type of novel reagents to study DNA topology and topoisomerases by FRET and a new method for high throughput drug screening against DNA topoisomerases for anticancer drug discovery and antibiotics discovery. In 2022, the anticancer drug discovery market size was worth $172.8 billion, and is expected to reach $335 billion by 2032.
Florida International University’s novel tools for DNA topology and topoisomerases research technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.
